Companies / Candel Therapeutics, Inc. / Activity
Activity — Candel Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Paul B Manning Director | Buy | Common Stock | $3.00M | +550K +24.87% | 2,763,527 3.61% of shares | high |
| Jun 23, 2026 | Papa Joseph C Director | Grant | Stock Option (Right to Buy) | — | +32K | 32,000 0.04% of shares | low |
| Mar 31, 2026 | Papa Joseph C Director | Grant | Stock Option (Right to Buy) | — | +3K | 2,795 <0.01% of shares | low |
| Jan 26, 2026 | Tyagarajan Seshu Executive | Grant | Stock Option (Right to Buy) | — | +154K | 154,000 0.20% of shares | low |
| Jan 26, 2026 | Nichols William Garrett Executive | Grant | Stock Option (Right to Buy) | — | +137K | 136,500 0.18% of shares | low |
| Jan 26, 2026 | Schoch Charles Executive | Grant | Stock Option (Right to Buy) | — | +232K | 232,000 0.30% of shares | low |
| Jan 26, 2026 | Tak Paul Peter CEO | Grant | Stock Option (Right to Buy) | — | +629K | 629,000 0.82% of shares | low |
| Jan 26, 2026 | Barone Francesca Executive | Grant | Stock Option (Right to Buy) | — | +232K | 232,000 0.30% of shares | low |